(S (NP-SBJ (NP (VBN Reduced) (NN susceptibility)) (PP (TO to) (NP (NP (NN HIV-1) (NN infection)) (PP (IN of) (NP (JJ ethyl-methanesulfonate-treated) (NN CEM) (NNS subclones)))))) (VP (VBZ correlates) (PP (IN with) (NP (NP (DT a) (NN blockade)) (PP (IN in) (NP (PRP$ their) (NN protein) (NN kinase) (NN C) (NN signaling) (NN pathway)))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN described) (NP (NP (DT the) (NN isolation)) (PP (IN of) (NP (NP (ADJP (RB chemically) (VBN induced)) (NN CEM) (NNS subclones)) (SBAR (WHNP-33 (WDT that)) (S (NP-SBJ (-NONE- *T*-33)) (VP-COOD (VP (VBP express) (NP (NN CD4) (NNS receptors))) (CC and) (VP (VBP bind) (NP (JJ soluble) (NN gp120))) (, ,) (RB yet) (VP (VBP show) (NP (NP (DT a) (ADJP (RB markedly) (VBN reduced)) (NN susceptibility)) (PP (TO to) (NP (NP (NN infection)) (PP (IN with) (NP (NN HIV-1))))))))))))))) (. .))
(S (NP-SBJ-34 (CD Two) (NNS subclones)) (VP (VBD were) (VP (VBN found) (S (NP-SBJ (-NONE- *-34)) (VP (TO to) (VP (VB have) (NP (NP (DT an) (JJ abnormal) (NN response)) (PP (TO to) (NP (DT the) (NP (NP (NN protein) (NN kinase) (NN C)) (PRN (-LRB- -LRB-) (NP (NN PKC)) (-RRB- -RRB-))) (NN activator) (NN PMA))))))))) (. .))
(S (NP-SBJ (NN PMA) (NN treatment)) (VP (VBD induced) (NP (NP-COOD (NP (NN CD3)) (CC and) (NP (NP (NN CD25)) (PRN (-LRB- -LRB-) (NP (NN IL-2R)) (-RRB- -RRB-)))) (NNS receptors)) (PP-COOD (PP (IN on) (NP (DT the) (JJ parental) (NN line))) (CC and) (PP (IN on) (NP (JJ other) (JJ ethyl-methanesulfonate-derived) (NNS subclones))) (, ,) (CC but) (PP (RB not) (IN on) (NP (DT these) (CD two) (NNS mutants))))) (. .))
(S (NP-SBJ-35 (NP (JJ Direct) (NNS assays)) (PP (IN of) (NP (NN PKC) (NN activity)))) (VP (VBD were) (VP (VBN conducted) (NP (-NONE- *-35)))) (. .))
(S (NP-SBJ-36 (JJ Total) (JJ cellular) (NN PKC) (JJ enzymatic) (NN activity)) (VP (VBD was) (VP (VBN found) (S (NP-SBJ (-NONE- *-36)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ normal)) (PP (IN in) (NP (DT these) (NNS subclones)))))))) (. .))
(S (NP-SBJ (JJ PMA-induced) (NN CD4) (NN down-modulation)) (VP (VBD occurred) (ADVP (RB normally))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (NN activation)) (PP (IN of) (NP (NN c-raf) (NN kinase)))) (VP (VBD was) (ADJP-PRD (JJ normal))) (. .))
(S (SBAR-ADV (IN Since) (S (NP-SBJ (NN HIV-1) (JJ long) (JJ terminal) (NN repeat)) (VP (VBZ contains) (NP (CD two) (JJ functional) (NP (NP (JJ nuclear) (NN factor) (NN kB)) (PRN (-LRB- -LRB-) (NP (NN NF-kB)) (-RRB- -RRB-))) (JJ regulatory) (NNS elements))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD studied) (NP (NP (DT the) (NN ability) (S (-NONE- *ICH*-37))) (PP (IN of) (NP (NN PMA))) (S-37 (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB induce) (NP (NN NF-kB) (NN binding) (NN activity)) (PP (IN by) (NP (JJ different) (NNS assays)))))))) (. .))
(S (NP-SBJ (NP (NP (NP (NN Chloramphenicol) (NN acetyl) (NN transferase)) (PRN (-LRB- -LRB-) (NP (NN CAT)) (-RRB- -RRB-))) (NNS assays)) (VP (VBG using) (NP (DT the) (NN HIV-1) (ADJP (-LRB- -LRB-) (CD -139) (-RRB- -RRB-) (JJ long) (JJ terminal) (JJ repeat-CAT)) (NN construct)))) (VP (VBD showed) (NP (NP (DT no) (NN PMA) (NN induction)) (PP (IN of) (NP (NN CAT) (NN activity)))) (PP (IN in) (NP (DT these) (NNS subclones))) (-LRB- -LRB-) (PP (IN unlike) (NP-COOD (NP (DT the) (JJ parental) (NN line)) (CC and) (NP (JJ other) (NNS subclones)))) (-RRB- -RRB-)) (. .))
(S (NP-SBJ (NP (JJ Okadaic) (NN acid)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NNS phosphatases) (NP-COOD (NP (CD 1)) (CC and) (NP (NN 2A)))))) (, ,)) (VP (VBD did) (RB not) (VP (VB overcome) (NP (NP (DT the) (NN defect)) (PP (IN in) (NP (DT these) (NNS subclones)))))) (. .))
(S (NP-SBJ (NP (NN Gel) (NN retardation) (NNS assays)) (, ,) (VP (VBG using) (NP (NP (DT a) (NN 32P-probe)) (VP (VBG containing) (NP-COOD (NP (DT the) (NN HIV-1) (NN NF-kB) (NN probe)) (CC and) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (JJ PMA-treated) (NNS cells)))))))) (, ,)) (VP (VBD showed) (NP (NP (ADJP (RB significantly) (VBN reduced)) (NN induction)) (PP (IN of) (NP (JJ nuclear) (NN NF-kB) (NN binding) (NNS proteins)))) (PP (IN in) (NP (DT these) (CD two) (NNS subclones))) (PP (VBN compared) (PP (IN with) (NP-COOD (NP (JJ wild) (NN type) (NN CEM)) (CC and) (NP (DT a) (NN control) (NN subclone)))))) (. .))
(S (NP-SBJ (NP (JJ Deoxycholate) (NN treatment)) (PP (IN of) (NP (NP (JJ cytoplasmic) (NNS extracts)) (PP (IN from) (NP (DT these) (NNS subclones)))))) (VP (VBD released) (NP (ADJP (JJ much) (VBN reduced)) (NN NF-kB) (NN binding) (NNS proteins)) (PP (IN from) (NP (PRP$ their) (JJ cytoplasmic) (NNS pools)))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ (NP (JJ reduced) (NNS levels)) (PP (IN of) (NP (JJ PKC-induced) (JJ nuclear) (NN NF-kB) (NN activity))) (PP (IN in) (NP (CD two) (NN T) (NN cell) (NNS subclones)))) (VP-COOD (VP (VBD did) (RB not) (VP (VB affect) (NP (PRP$ their) (JJ normal) (NN cell) (NN growth)))) (, ,) (CC but) (VP (VBD correlated) (PP (IN with) (NP (NP (DT a) (JJ pronounced) (NN reduction)) (PP (IN in) (NP (NP (PRP$ their) (NN susceptibility)) (PP (TO to) (NP (NN HIV-1) (NN infection))))))))) (. .))
